Biological Information
Background Information:
The cAMP Hunter™ Semaglutide bioassay provides a robust, and highly sensitive functional, cell-based assay to monitor 3’-5’-cyclic adenosine monophosphate (cAMP) production in cells, as a result of ligand (e.g. Exendin-4)-mediated activation of the GLP-1 receptor. The bioassay kit contains all the materials needed for a complete assay, including cells, detection reagents, cell plating reagent, positive control agonist, and assay plates. The ready-to-use cryopreserved cells have been manufactured to ensure assay reproducibility and faster implementation from characterization to QC lot-release. This bioassay has been optimized for a 96-well format. Note that control agonist for stimulating the cells, recombinant human Exendin-4, is not included in the kit, and may be purchased separately. This assay has been optimized and qualified with Semaglutide (not supplied in the bioassay kit). Ozempic® is a registered trademark of Novo Nordisk A/S. The cAMP Hunter™ Semaglutide Bioassay Kit is an easy-to-use cell-based assay to measure drug potency and detect neutralizing antibodies.
Please reach out to Tech Support at DiscoverXSupportUS@discovery.eurofinsus.com for lot specific CoA.
Target Class:
GPCR
Family:
Glucagon
Sub Family:
Class B
Protein Name:
GLP-1
Protein Aliases:
GLP-1-R|GLP-1R
Accession Number:
NM_002062.3
UniProt Number:
P43220
Gene Name:
GLP1R
Gene ID:
2740
Target Species:
Human
Cell Background:
CHO-K1
Usage
Product Type:
Bioassay Kits
Application:
Potency, Commercial Release & Stability
Kit Components:
Storage Conditions:
Store in vapor phase of liquid nitrogen.
Usage disclaimer:
These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.
Assay Information
Assay Type:
Cell Based, Qualified
Assay Measures:
cAMP Detection
Detection Method:
Chemiluminescence
Bioassay Data
INN Drug Name:
Semaglutide
Qualified With:
Ozempic®
Trademark Statement:
Ozempic® is a registered trademark of Novo Nordisk A/S
Clinical Relevance
Therapeutic Area:
Metabolic Diseases
Additional Information
Brand:
cAMP Hunter™